Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review

Shao, Zhiying; Liu, Xin; Peng, Chanjuan; Wang, Liping; Xu, Dong

doi:10.1186/s12957-021-02401-4

Table 1 The basic characteristics of identified studies in this review

From: Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review

Study	Country	Year	Type	Disease	Study arms	NP	Treatment phase
Taku et al. [25]	Japan	2004	Retrospective	HCC with chronic liver disease	TACE + PVE	17	Preoperative treatment
Ogata et al. [28]	France	2006	Retrospective	HCC with chronic liver disease	TACE + PVE vs. PVE	36	Preoperative treatment
Imamura et al. [31]	Japan	2008	Prospective	HCC	TACE + PVE	45	Preoperative treatment
Yoo et al. [32]	Korea	2011	Retrospective	HCC	TACE + PVE vs. PVE	135	Preoperative treatment
Xu et al. [33]	China	2014	Retrospective	HCC	TACE + PVE	37	Preoperative treatment
Choi et al. [34]	Korea	2015	Retrospective	HCC	TACE + PVE	113	Preoperative treatment
Ronot et al. [35]	France	2016	Retrospective	HCC	TACE + PVE	54	Preoperative treatment
Peng et al. [36]	China	2017	Prospective	Large HCC	TACE + PVE vs. PVE	13	Preoperative treatment
Terasawa et al. [37]	France	2020	Prospective	Large HCC	Simultaneous TACE + PVE vs. sequential TACE + PVE vs. PVE	55	Preoperative treatment
Zhang et al. [38]	China	2020	Retrospective	Large HCC	TACE + PVE vs. TACE	51	Preoperative treatment
Park et al. [39]	Korea	2020	Retrospective	HCC	TACE + PVE vs. PVE vs. TACE vs. naïve control	205	Preoperative treatment
Peng et al. [40]	America	2012	Retrospective	HCC with cirrhosis	TACE + PVE vs. PVE vs. TACE	56	Preoperative treatment
Sommacale et al. [41]	France	2014	Retrospective	HCC	TACE + PVE vs. PVE	24	Preoperative treatment
Mao et al. [42]	China	2002	perspective	HCC	TACE + PVE	209	Palliative treatment
Kang et al. [43]	Korea	2009	Retrospective	HCC	TACE + PVE	25	Salvage treatment
Tan et al. [18]	China	2014	Retrospective	HCC with PVTT	TACE + PVE vs. TACE	116	Palliative treatment
Okabe et al. [44]	Japan	2012	Retrospective	HCC	TACE + PVE vs. TACE	39	Palliative treatment
Wu et al. [45]	China	2003	Retrospective	HCC	TACE + PVCE vs. PVCE	176	Palliative treatment
Liang et al. [46]	China	2009	Prospective	HCC	TACE + PVCE vs. TACE	32	Palliative treatment
He et al. [47]	China	2010	Prospective	PLC	TACE + PVCE vs. TACE	48	Palliative treatment
Zhang et al.[48]	China	2012	Prospective	HCC with PVTT	TACE vs. PVE vs. TACE + PVCE	87	Postoperative treatment
Guo et al. [49]	China	2011	Prospective	HCC	TACE + PVCE vs. TACE	36	Palliative treatment
Jia et al. [50]	China	2017	Prospective	HCC	TACE + PVCE vs. TACE	48	Palliative treatment
Yin et al. [51]	China	2007	Prospective	HCC	TACE + PVCE	54	Palliative treatment
Li et al. [52]	China	2006	Prospective	HCC	TACE + PVCE vs. TACE vs. naïve control	131	Postoperative treatment
Dai et al. [7]	China	2019	Retrospective	HCC with PVTT	TACE + PVCE vs. TACE	119	Postoperative treatment
He et al. [53]	China	2018	Prospective	HCC	TACE + PVCE vs. TACE	133	Palliative treatment
Zhao et al. [54]	China	2009	Retrospective	HCC with PVTT	TACE + PVCE vs. TACE	48	Palliative treatment

HCC Hepatocellular carcinoma, PVTT Portal vein tumor thrombus, TACE Transcatheter arterial chemoembolization, PVE Transcatheter arterial chemoembolization, PVCE Portal vein chemoembolization, NP Number of patients

Back to article page

ISSN: 1477-7819

Contact us

General enquiries: journalsubmissions@springernature.com

World Journal of Surgical Oncology

Contact us